• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

如何应对非典型神经性厌食症?对沃尔什等人(2023年)的评论。

What to do about atypical anorexia nervosa? Commentary on Walsh et al. (2023).

作者信息

First Michael B

机构信息

Department of Psychiatry, Columbia University Irving Medical Center, New York, NY, USA.

出版信息

Int J Eat Disord. 2023 Apr;56(4):821-823. doi: 10.1002/eat.23903. Epub 2023 Feb 1.

DOI:10.1002/eat.23903
PMID:36722504
Abstract

Changes made to the DSM Eating Disorders over the years have aimed to reduce the prevalence of the residual DSM Eating Disorder categories (e.g., Other Specified Eating Disorder). Atypical Anorexia Nervosa (AN), included since DSM-IV as an example of a presentation not meeting criteria for a specific eating disorder, appears to be more prevalent than AN. It is defined as meeting all of the criteria for AN except that, after significant weight loss, weight is at or above normal. As suggested by the Walsh et al. review, lack of definitional precision will likely complicate efforts to determine whether atypical AN is best considered a variant of AN or a distinct category. Problems with the current definition of atypical AN include (1) a lack of precision regarding what constitutes "significant" weight loss; (2) whether the weight loss can occur at any point in the individual's lifetime; and (3) whether there an upper limit to weight being above normal. It is suggested that researchers develop consensus diagnostic criteria and assessment tools to facilitate the collection of empirical data about atypical AN in order to lay the groundwork for future decisions about its nosological status.

摘要

多年来对《精神疾病诊断与统计手册》(DSM)中饮食失调症的修订旨在降低残余DSM饮食失调类别(如其他特定的饮食失调症)的患病率。非典型神经性厌食症(AN)自DSM-IV起被纳入,作为一种不符合特定饮食失调症标准的表现示例,其患病率似乎高于神经性厌食症。它被定义为除了在显著体重减轻后体重处于或高于正常水平外,符合神经性厌食症的所有标准。正如沃尔什等人的综述所指出的,定义缺乏精确性可能会使确定非典型AN最好被视为神经性厌食症的一种变体还是一个独立类别变得复杂。非典型AN当前定义存在的问题包括:(1)对于什么构成“显著”体重减轻缺乏精确性;(2)体重减轻是否可以在个体生命中的任何时候发生;以及(3)体重高于正常水平是否有上限。建议研究人员制定共识性诊断标准和评估工具,以促进收集有关非典型AN的实证数据,从而为未来关于其分类学地位的决策奠定基础。

相似文献

1
What to do about atypical anorexia nervosa? Commentary on Walsh et al. (2023).如何应对非典型神经性厌食症?对沃尔什等人(2023年)的评论。
Int J Eat Disord. 2023 Apr;56(4):821-823. doi: 10.1002/eat.23903. Epub 2023 Feb 1.
2
Sexual Harassment and Prevention Training性骚扰与预防培训
3
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
4
A systematic review comparing atypical anorexia nervosa and anorexia nervosa.一项比较非典型神经性厌食症和神经性厌食症的系统评价。
Int J Eat Disord. 2023 Apr;56(4):798-820. doi: 10.1002/eat.23856. Epub 2022 Dec 12.
5
Individual psychological therapy in the outpatient treatment of adults with anorexia nervosa.成人神经性厌食症门诊治疗中的个体心理治疗。
Cochrane Database Syst Rev. 2015 Jul 27;2015(7):CD003909. doi: 10.1002/14651858.CD003909.pub2.
6
Atypical antipsychotics for disruptive behaviour disorders in children and youths.用于治疗儿童和青少年破坏性行为障碍的非典型抗精神病药物。
Cochrane Database Syst Rev. 2017 Aug 9;8(8):CD008559. doi: 10.1002/14651858.CD008559.pub3.
7
Interventions for preventing eating disorders in children and adolescents.预防儿童和青少年饮食失调的干预措施。
Cochrane Database Syst Rev. 2002;2002(2):CD002891. doi: 10.1002/14651858.CD002891.
8
Eating disorder psychopathology, psychiatric impairment, and symptom frequency of atypical anorexia nervosa versus anorexia nervosa: A systematic review and meta-analysis.进食障碍病理心理学、精神障碍及非典型神经性厌食症与神经性厌食症的症状频率:系统回顾和荟萃分析。
Int J Eat Disord. 2024 Apr;57(4):761-779. doi: 10.1002/eat.23989. Epub 2023 Jun 14.
9
Digital augmentation of aftercare for patients with anorexia nervosa: the TRIANGLE RCT and economic evaluation.神经性厌食症患者后期护理的数字化增强:TRIANGLE随机对照试验及经济评估
Health Technol Assess. 2025 Jul;29(31):1-162. doi: 10.3310/ADLS3672.
10
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.